Eton Pharmaceuticals Inc (ETON) support and resistance · rev $39.0M
Eton Pharmaceuticals Inc (ETON) is a drug manufacturers - specialty & generic company listed on US.
This page maps Eton Pharmaceuticals Inc (ETON) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ETON revenue for 2024-12-31 was $39.0M. Net income was -$3.8M. Revenue was up 23.3% from 2023-12-31 to 2024-12-31. ETON currently screens at market cap $797.9M.
ETON currently screens at market cap $797.9M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ETON 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ETON quote page for the session range and the stock page for the full model.
Not investment advice.